Patrick Hsu
Patrick D. Hsu | |
|---|---|
| Born | Patrick David Hsu 1993 (age 32–33) |
| Citizenship | |
| Education | |
| Known for | CRISPR, machine learning, synthetic biology, gene therapy |
| Awards |
|
| Scientific career | |
| Fields | Bioengineering, Gene editing, Synthetic biology, Machine learning |
| Workplaces | Stanford University, Arc Institute |
| Thesis | Genome engineering and RNA-guided systems (2014) |
| Feng Zhang | |
| Website | Hsu Lab |
Patrick D. Hsu (born 1993) is an American bioengineer, entrepreneur, and investor specializing in CRISPR, machine learning, synthetic biology, and gene therapy. He is an assistant professor of pathology at Stanford University and a co-founder of Arc Institute, a research organization focused on accelerating biomedical discovery. He is a board director of Notion and on the scientific advisory board of Amgen.